It was another solid week of gains for the iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) as investors took their cue from bullish earnings reports out of Biogen (NASDAQ:BIIB) and Amgen (NASDAQ:AMGN), along with continued takeover rumors floating all around the biotech space.